Cargando…

The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort

There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Mora, María Elena, Genis-Mendoza, Alma Delia, Villatoro Velázquez, Jorge Ameth, Bustos-Gamiño, Marycarmen, Bautista, Clara Fleiz, Camarena, Beatriz, Martínez-Magaña, José Jaime, Nicolini, Humberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961066/
https://www.ncbi.nlm.nih.gov/pubmed/36833803
http://dx.doi.org/10.3390/ijerph20043109
_version_ 1784895663494922240
author Medina-Mora, María Elena
Genis-Mendoza, Alma Delia
Villatoro Velázquez, Jorge Ameth
Bustos-Gamiño, Marycarmen
Bautista, Clara Fleiz
Camarena, Beatriz
Martínez-Magaña, José Jaime
Nicolini, Humberto
author_facet Medina-Mora, María Elena
Genis-Mendoza, Alma Delia
Villatoro Velázquez, Jorge Ameth
Bustos-Gamiño, Marycarmen
Bautista, Clara Fleiz
Camarena, Beatriz
Martínez-Magaña, José Jaime
Nicolini, Humberto
author_sort Medina-Mora, María Elena
collection PubMed
description There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 2016–17 National Survey of Drug, Alcohol, and Tobacco Use (Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016–2017). The data were collected from households using a cross-sectional, stratified, multistage design, with a confidence level of 90% and a response rate of 73.6%. The final sample included 56,877 completed interviews of individuals aged 12–65, with a subsample of 13,130 who answered the section on mental health. Symptoms of mania and hypomania (7.9%), depression (6.4%), and post-traumatic stress (5.7%) were the three main problems reported. Of this subsample, 56.7% reported using a legal or illegal drug without SUD, 5.4% reported SUD at one time on alcohol, 0.8% on tobacco, and 1.3% on medical or illegal drugs, 15.9% reported symptoms related to mental health, and 2.9% comorbidity. The prevalence found is consistent with those reported in previous studies, except for an increase in post-traumatic stress, which is consistent with the country’s increase in trauma.
format Online
Article
Text
id pubmed-9961066
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99610662023-02-26 The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort Medina-Mora, María Elena Genis-Mendoza, Alma Delia Villatoro Velázquez, Jorge Ameth Bustos-Gamiño, Marycarmen Bautista, Clara Fleiz Camarena, Beatriz Martínez-Magaña, José Jaime Nicolini, Humberto Int J Environ Res Public Health Review There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 2016–17 National Survey of Drug, Alcohol, and Tobacco Use (Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016–2017). The data were collected from households using a cross-sectional, stratified, multistage design, with a confidence level of 90% and a response rate of 73.6%. The final sample included 56,877 completed interviews of individuals aged 12–65, with a subsample of 13,130 who answered the section on mental health. Symptoms of mania and hypomania (7.9%), depression (6.4%), and post-traumatic stress (5.7%) were the three main problems reported. Of this subsample, 56.7% reported using a legal or illegal drug without SUD, 5.4% reported SUD at one time on alcohol, 0.8% on tobacco, and 1.3% on medical or illegal drugs, 15.9% reported symptoms related to mental health, and 2.9% comorbidity. The prevalence found is consistent with those reported in previous studies, except for an increase in post-traumatic stress, which is consistent with the country’s increase in trauma. MDPI 2023-02-10 /pmc/articles/PMC9961066/ /pubmed/36833803 http://dx.doi.org/10.3390/ijerph20043109 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Medina-Mora, María Elena
Genis-Mendoza, Alma Delia
Villatoro Velázquez, Jorge Ameth
Bustos-Gamiño, Marycarmen
Bautista, Clara Fleiz
Camarena, Beatriz
Martínez-Magaña, José Jaime
Nicolini, Humberto
The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title_full The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title_fullStr The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title_full_unstemmed The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title_short The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
title_sort prevalence of symptomatology and risk factors in mental health in mexico: the 2016–17 encodat cohort
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961066/
https://www.ncbi.nlm.nih.gov/pubmed/36833803
http://dx.doi.org/10.3390/ijerph20043109
work_keys_str_mv AT medinamoramariaelena theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT genismendozaalmadelia theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT villatorovelazquezjorgeameth theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT bustosgaminomarycarmen theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT bautistaclarafleiz theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT camarenabeatriz theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT martinezmaganajosejaime theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT nicolinihumberto theprevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT medinamoramariaelena prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT genismendozaalmadelia prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT villatorovelazquezjorgeameth prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT bustosgaminomarycarmen prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT bautistaclarafleiz prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT camarenabeatriz prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT martinezmaganajosejaime prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort
AT nicolinihumberto prevalenceofsymptomatologyandriskfactorsinmentalhealthinmexicothe201617encodatcohort